DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 8, 2014

Primary Completion Date

April 30, 2016

Study Completion Date

August 11, 2016

Conditions
Psoriasis
Interventions
DRUG

DFD06 Cream

DRUG

Clobetasol Propionate Cream 0.05%

Trial Locations (15)

27262

Dermatology Consulting Services, High Point

29650

Radiant Research, Inc., Greer

30060

Marietta Dermatology Clinical Research, Inc., Marietta

33027

FXM Research Miramar, Miramar

33144

International Dermatology Research, Inc., Miami

33175

FXM Research Corp., Miami

33624

Forward Clinical Trials, Tampa

33781

Belleair Research, Pinellas Park

40202

Determatology Specialists Research, LLC, Louisville

68114

Quality Clinical Research, Inc., Omaha

73112

Lynn Health Science Institute, Oklahoma City

85202

Agave Clinical Research, LLC, Mesa

85308

Advanced Research Associates, Glendale

91436

T. Joseph Raoof, MD, Inc., Encino

02919

Clinical Partners, LLC, Johnston

All Listed Sponsors
lead

Promius Pharma, LLC

INDUSTRY

NCT02131324 - DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis | Biotech Hunter | Biotech Hunter